Williams, Wells Elected To Inovio Biomedical Board

Posted on: Tue, 27 Oct 2009 04:02:00 EDT


Symbols: INO
Oct 27, 2009 (FinancialWire via COMTEX) --
INO | Quote | Chart | News | PowerRating -- (Comment on this article at http://www.financialwire.net/2009/10/27/williams-wells-elected-to-inovio-biomedical-board/)

October 27, 2009 (FinancialWire) -- Inovio Biomedical Corp.'s (AMEX: INO | Quote | Chart | News | PowerRating) (Current Market Cap: $123.19 Mil.) board has elected David J. Williams and Keith H. Wells as directors.

Williams is the former chairman and CEO of Sanofi Pasteur, the vaccine business of Sanofi-Aventis Group. Wells is a senior member of the Biologics Consulting Group and former director of vaccine development for The Salk Institute.

San Diego-based Inovio Biomedical is focused on the design, development, and delivery of a new generation of vaccines, called DNA vaccines, to prevent and treat cancers and infectious diseases.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

http://www.financialwire.net

For full details on Inovio Biomedical Corp (INO) INO. Inovio Biomedical Corp (INO) has Short Term PowerRatings at TradingMarkets. Details on Inovio Biomedical Corp (INO) Short Term PowerRatings is available at This Link.

UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
Thursday February 11 04:30 PM
* Attendance is strictly limited and are filled on a first-come, first-served basis.